Principal Financial Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-12,845
| Closed | -$191K | – | 2336 |
|
|
2018
Q3 | $191K | Buy |
12,845
+249
| +2% | +$3.7K | ﹤0.01% | 2177 |
|
|
2018
Q2 | $212K | Buy |
+12,596
| New | +$212K | ﹤0.01% | 2152 |
|
|
2017
Q4 | – | Sell |
-118,600
| Closed | -$1.75M | – | 2279 |
|
|
2017
Q3 | $1.75M | Buy |
118,600
+3,500
| +3% | +$51.6K | ﹤0.01% | 1758 |
|
|
2017
Q2 | $1.61M | Hold |
115,100
| – | – | ﹤0.01% | 1773 |
|
|
2017
Q1 | $1.96M | Hold |
115,100
| – | – | ﹤0.01% | 1731 |
|
|
2016
Q4 | $1.18M | Buy |
115,100
+1,416
| +1% | +$14.6K | ﹤0.01% | 1788 |
|
|
2016
Q3 | $1.15M | Buy |
113,684
+984
| +0.9% | +$9.95K | ﹤0.01% | 1751 |
|
|
2016
Q2 | $1.27M | Sell |
112,700
-2,900
| -3% | -$32.6K | ﹤0.01% | 1725 |
|
|
2016
Q1 | $1.58M | Hold |
115,600
| – | – | ﹤0.01% | 1667 |
|
|
2015
Q4 | $2.19M | Sell |
115,600
-82,100
| -42% | -$1.56M | ﹤0.01% | 1616 |
|
|
2015
Q3 | $3.71M | Buy |
197,700
+4,600
| +2% | +$86.3K | 0.01% | 1465 |
|
|
2015
Q2 | $2.88M | Buy |
193,100
+18,200
| +10% | +$271K | ﹤0.01% | 1606 |
|
|
2015
Q1 | $2.65M | Hold |
174,900
| – | – | ﹤0.01% | 1596 |
|
|
2014
Q4 | $2.33M | Sell |
174,900
-3,500
| -2% | -$46.6K | ﹤0.01% | 1651 |
|
|
2014
Q3 | $2.25M | Sell |
178,400
-55,600
| -24% | -$701K | ﹤0.01% | 1628 |
|
|
2014
Q2 | $2.36M | Buy |
234,000
+125,485
| +116% | +$1.27M | ﹤0.01% | 1648 |
|
|
2014
Q1 | $1.46M | Buy |
+108,515
| New | +$1.46M | ﹤0.01% | 1718 |
|